Speed, confidence, and clarity with the Agilent MAM solution

15 Jul 2026

Agilent's MAM Solutions Guide presents an integrated Multi-Attribute Method (MAM) workflow designed to support the transition of MAM from biopharmaceutical R&D into regulated quality control environments. The solution combines dedicated software, LC and LC/MS instrumentation, peptide mapping columns, standards, consumables, and compliance-ready data management tools to enable critical quality attribute (CQA) monitoring and new peak detection (NPD) workflows.

Designed around USP <1060> guidance, the platform aims to simplify method transfer, reduce training requirements, improve data integrity, streamline system suitability testing, and support routine QC implementation of peptide mapping and mass spectrometry-based product characterization. The guide highlights Agilent's focus on usability, compliance, robustness, and lower operational complexity for biopharmaceutical manufacturing and batch release applications.

Resource details:

Resource type: Product brochure
Page count: 8
Read time: 14 mins

Links

Tags

Mass SpectrometryMass spectrometry (MS) is a powerful analytical technique used to identify and quantify molecules based on the mass-to-charge ratio of gas-phase ions. It provides detailed information about the structure, composition, and properties of compounds and is widely used across fields such as environmental monitoring, materials science, drug discovery and development, food and beverage testing, and wider chemical research. Key MS techniques include tandem mass spectrometry (MS/MS), liquid chromatography–mass spectrometry (LS-MS) and inductively coupled plasma (ICP-MS). Choosing from these wide range of techniques and technologies can be a daunting task, so keep up to date with scientific applications, performance expectations, and customer reviews here all in one place. Visit our product directory to receive quotes direct from the manufacturer. QCPeptide MappingBiopharmaceuticalsBiopharmaceuticals are proteins and other compounds (such as nucleic acids) produced by living organisms that have uses as therapeutics or for in vivo diagnostics. The most well known example of a biopharmaceutical product, and the first to be approved for therapeutic use, was recombinant human insulin.